Retatrutide

Retatrutide is an investigational triple-agonist peptide being researched for its potential effects on weight management, metabolic function, and glucose regulation. It works by targeting GLP-1, GIP, and glucagon receptors, which are associated with appetite control, energy expenditure, and insulin activity. In research settings, Retatrutide has gained attention for its potential to support significant body weight reduction and improved metabolic balance. It is commonly studied in peptide and obesity-related research for its long-acting activity and multi-pathway mechanism.